Dynavax Technologies
DVAX
#4999
Rank
A$2.53 B
Marketcap
A$21.55
Share price
0.00%
Change (1 day)
-1.80%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$52.34 Million, an increase over its 2023 earnings that were of A$3.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-212.22%
2024 A$52.34 M1475.31%
2023 A$3.32 M-99.2%
2022 A$0.41 B238.78%
2021 A$0.12 B-257.89%
2020 -A$78.11 Million-58.58%
2019 -A$0.19 Billion-9.32%
2018 -A$0.21 Billion60.44%
2017 -A$0.13 Billion-15.8%
2016 -A$0.16 Billion4.22%
2015 -A$0.15 Billion16.54%
2014 -A$0.13 Billion37.09%
2013 -A$92.45 Million
2010 -A$66.17 Million214.85%
2009 -A$21.02 Million-37.33%
2008 -A$33.54 Million-66.07%
2007 -A$98.85 Million16.92%
2006 -A$84.55 Million170.36%
2005 -A$31.28 Million33.39%
2004 -A$23.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.17 B-30,175.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.48 B-26,587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.16 B-4,693.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.62 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.17 B-66,267.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.61 B-41,731.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.75 B-29,301.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$28.72 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.99 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel